Clinical Trial Update: Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase I/II randomized trial evaluated neoadjuvant chemoradiotherapy with S-1 and radiotherapy vs. S-1 plus oxaliplatin and radiotherapy in gastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Samsung Medical Center | Conditions: Phase I: To Determine the Maximum Tolerated Dose (MTD), Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin | Phase 1, Phase 2 | Status: TERMINATED